Yuanta Financial Holdings Group logo

Yuanta Financial Holdings Group

Asia, T'ai-pei, Taiwan, Taipei

Description

Yuanta Financial Holdings Group is a financial services firm that specializes in banking, investment consulting, and asset management.

Investor Profile

Yuanta Financial Holdings Group has made 3 investments, with 1 in the past 12 months and 33% as lead.

Stage Focus

  • Series B (67%)
  • Series A (33%)

Country Focus

  • United States (67%)
  • China (33%)

Industry Focus

  • Information Technology
  • Software
  • Biopharma
  • Biotechnology
  • Health Care
  • Medical
  • Oncology
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Yuanta Financial Holdings Group frequently co-invest with?

China Universal Asset Management
Asia, Shanghai, China, Shanghai
Co-Investments: 1
Center Ventures
Asia, T'ai-pei, Taiwan, Taipei
Co-Investments: 1
GoldTech
Asia, Beijing, China, Beijing
Co-Investments: 1
HI
Asia, T'ai-pei, Taiwan, Taipei
Co-Investments: 1
Cathay Capital
Europe, Ile-de-France, France, Paris
Co-Investments: 1
Paragon Investments
North America, Kansas, United States, Silver Lake
Co-Investments: 1
Chengwei Capital
Asia, Shanghai, China, Shanghai
Co-Investments: 1
99Fund
Asia, Shanghai, China, Shanghai
Co-Investments: 1
CI
Asia, Jiangsu, China, Taiwan
Co-Investments: 1
CT
Asia, T'ai-pei, Taiwan, Taipei
Co-Investments: 1

What are some of recent deals done by Yuanta Financial Holdings Group?

GRAID Technology

Santa Clara, California, United States

GRAID Technology is used for a modern software composable environment through its software and hardware solutions.

Information TechnologySoftware
Series BMar 4, 2025
Amount Raised: $30,000,000
GRAID Technology

Santa Clara, California, United States

GRAID Technology is used for a modern software composable environment through its software and hardware solutions.

Information TechnologySoftware
Series AJan 25, 2022
Amount Raised: $15,000,000
TOT BIOPHARM

Suzhou, Jiangsu, China

TOT BIOPHARM is a clinical-stage biopharmaceutical company dedicated to developing and commercializing innovative oncology drugs.

BiopharmaBiotechnologyHealth CareMedicalOncologyPharmaceutical
Series BAug 8, 2018
Amount Raised: $102,000,000